Characterizing Eckol as a Therapeutic Aid: A Systematic Review

Mar Drugs. 2019 Jun 18;17(6):361. doi: 10.3390/md17060361.

Abstract

The marine biosphere is a treasure trove of natural bioactive secondary metabolites and the richest source of structurally diverse and unique compounds, such as phlorotannins and halo-compounds, with high therapeutic potential. Eckol is a precursor compound representing the dibenzo-1,4-dioxin class of phlorotannins abundant in the Ecklonia species, which are marine brown algae having a ubiquitous distribution. In search of compounds having biological activity from macro algae during the past three decades, this particular compound has attracted massive attention for its multiple therapeutic properties and health benefits. Although several varieties of marine algae, seaweed, and phlorotannins have already been well scrutinized, eckol deserves a place of its own because of the therapeutic properties it possesses. The relevant information about this particular compound has not yet been collected in one place; therefore, this review focuses on its biological applications, including its potential health benefits and possible applications to restrain diseases leading to good health. The facts compiled in this review could contribute to novel insights into the functions of eckol and potentially enable its use in different uninvestigated fields.

Keywords: Ecklonia; bioactivity; eckol; phlorotannin; seaweed.

Publication types

  • Systematic Review

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Biological Factors / pharmacology
  • Biological Factors / therapeutic use
  • Dioxins / pharmacology*
  • Dioxins / therapeutic use*
  • Humans
  • Phaeophyceae / chemistry
  • Seaweed / chemistry

Substances

  • Antioxidants
  • Biological Factors
  • Dioxins
  • eckol